NDC 51672-4119-9 - Nortriptyline Hydrochloride

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 51672-4119
Requested NDC: 51672-4119-9
Package NDCs from labels: 51672-4119-9
Manufacturer: Taro Pharmaceuticals U.S.A., Inc.
Effective date: 2008-11-04
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Nortriptyline Hydrochloride Oral Solution, USP	Taro Pharmaceuticals U.S.A., Inc.	2008-11-04	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51672-4119-9	Nortriptyline Hydrochloride	473 mL in 1 BOTTLE	SOLUTION	473		1
51672-4119-9	Nortriptyline Hydrochloride	1 in 1 CARTON	SOLUTION	1		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51672-4119	NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.]	1	2 package rows	20090320_C1DFE613-D8AC-4F18-9AAF-5F11044DE2B1.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Nortriptyline Hydrochloride	ACTIVE INGREDIENT	00FN6IH15D	NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.]	1
Nortriptyline	ACTIVE MOIETY	BL03SY4LXB	NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.]	1
alcohol	INACTIVE INGREDIENT	3K9958V90M	NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.]	1
benzoic acid	INACTIVE INGREDIENT	8SKN0B0MIM	NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.]	1
cherry flavor (artificial)	INACTIVE INGREDIENT		NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.]	1
sorbitol	INACTIVE INGREDIENT	506T60A25R	NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.]	1
water	INACTIVE INGREDIENT	059QF0KO0R	NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Nortriptyline Hydrochloride	NORTRIPTYLINE HYDROCHLORIDE	PAI Holdings, LLC dba PAI Pharma	3fcabf90-357a-4a06-b680-9572dc28bcfe	2026-01-26	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 312036
Nortriptyline Hydrochloride	NORTRIPTYLINE HYDROCHLORIDE	Advagen Pharma Ltd	bef9e24d-e730-4801-ab25-75e7d6bde225	2026-01-07	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 312036
094D8D59-7520-2EDD-6559-9FFE46AD633A			C1DFE613-D8AC-4F18-9AAF-5F11044DE2B1	2008-11-04	Boxed warning, Warnings, Adverse reactions	Exact identifier spl id: 094D8D59-7520-2EDD-6559-9FFE46AD633A spl set id: C1DFE613-D8AC-4F18-9AAF-5F11044DE2B1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.